Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) — Working Capital to Net Assets Ratio
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a Working Capital to Net Assets ratio of -0.1% as of March 2026. Working capital of $-207.95K (current assets of $1.42 Million minus current liabilities of $1.62 Million) is measured against net assets of $196.19 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Working Capital to Net Assets (2024–2025)
This chart shows how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at -0.1%, reflecting working capital of $-207.95K against net assets of $196.19 Million USD. For the complete balance sheet picture, see OACC current and non-current assets.
Annual Working Capital to Net Assets for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read total liabilities of Oaktree Acquisition Corp. III Life Scien for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.1% | $248.59K | $194.79 Million | $1.55 Million | $1.30 Million | ▼ -0.3 pp |
| 2024 | 0.4% | $831.00K | $187.50 Million | $1.56 Million | $727.32K | — |